Nouri Review

How Nouri scores

Nouri has closed. These scores describe what it published when we last checked it, before it stopped taking patients.

Six columns, each one computed from something Nouri published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.

• ✓Checked the listed price across 2 dose or plan tiers
• ✓Checked state coverage: all 50
• ✓Checked what the monthly price covers, and what it leaves out
• ✓Checked FDA warning letters for Nouri

Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.

Medications Nouri listed

Nouri listed compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.

Where Nouri is the wrong choice

No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.

• →If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
• →If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).

If none of these fits, our guide to alternatives to Nouri sets more sellers in the same category beside Nouri on price, states and what the price includes.